174 related articles for article (PubMed ID: 32737156)
1. Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.
Wen Y; Wang Y; Chelariu-Raicu A; Stur E; Liu Y; Corvigno S; Bartsch F; Redfern L; Zand B; Kang Y; Liu J; Baggerly K; Sood AK
Mol Cancer Ther; 2020 Sep; 19(9):1943-1954. PubMed ID: 32737156
[TBL] [Abstract][Full Text] [Related]
2. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY
Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362
[TBL] [Abstract][Full Text] [Related]
3. A Novel Mechanism of hPRL-G129R, a Prolactin Antagonist, Inhibits Human Breast Cancer Cell Proliferation and Migration.
Li R; Yang Y; Lan H; Wang Y; Ge Z; Liu X; Zhou Y; Zhang W; Xian L; Yuan H
Endocrinology; 2023 Nov; 164(12):. PubMed ID: 37934803
[TBL] [Abstract][Full Text] [Related]
4. Prolactin induces apoptosis of lactotropes in female rodents.
Ferraris J; Zárate S; Jaita G; Boutillon F; Bernadet M; Auffret J; Seilicovich A; Binart N; Goffin V; Pisera D
PLoS One; 2014; 9(5):e97383. PubMed ID: 24859278
[TBL] [Abstract][Full Text] [Related]
5. Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies.
Standing D; Dandawate P; Anant S
Front Endocrinol (Lausanne); 2022; 13():1112987. PubMed ID: 36714582
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.
Wen Y; Zand B; Ozpolat B; Szczepanski MJ; Lu C; Yuca E; Carroll AR; Alpay N; Bartholomeusz C; Tekedereli I; Kang Y; Rupaimoole R; Pecot CV; Dalton HJ; Hernandez A; Lokshin A; Lutgendorf SK; Liu J; Hittelman WN; Chen WY; Lopez-Berestein G; Szajnik M; Ueno NT; Coleman RL; Sood AK
Cell Rep; 2014 Apr; 7(2):488-500. PubMed ID: 24703838
[TBL] [Abstract][Full Text] [Related]
7. Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer.
Xu C; Langenheim JF; Chen WY
Breast Cancer Res Treat; 2012 Jul; 134(1):157-69. PubMed ID: 22270933
[TBL] [Abstract][Full Text] [Related]
8. MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells.
Ding H; Buzzard GW; Huang S; Sehorn MG; Marcus RK; Wei Y
PLoS One; 2021; 16(6):e0252662. PubMed ID: 34077462
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.
Asad AS; Nicola Candia AJ; Gonzalez N; Zuccato CF; Abt A; Orrillo SJ; Lastra Y; De Simone E; Boutillon F; Goffin V; Seilicovich A; Pisera DA; Ferraris MJ; Candolfi M
Sci Rep; 2019 Dec; 9(1):19578. PubMed ID: 31862900
[TBL] [Abstract][Full Text] [Related]
10. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
Tan D; Chen KE; Khoo T; Walker AM
Cancer Lett; 2011 Nov; 310(1):101-8. PubMed ID: 21775057
[TBL] [Abstract][Full Text] [Related]
11. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
12. Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice.
Shao R; Nutu M; Weijdegård B; Egecioglu E; Fernandez-Rodriguez J; Tallet E; Goffin V; Ling C; Billig H
Biol Reprod; 2008 Oct; 79(4):748-57. PubMed ID: 18596217
[TBL] [Abstract][Full Text] [Related]
13. The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.
Sutherland A; Forsyth A; Cong Y; Grant L; Juan TH; Lee JK; Klimowicz A; Petrillo SK; Hu J; Chan A; Boutillon F; Goffin V; Egan C; Tang PA; Cai L; Morris D; Magliocco A; Shemanko CS
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26586670
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic Prolactin Regulation of Luteinizing Hormone Secretion in the Female Rat.
Grachev P; Li XF; Goffin V; O'Byrne KT
Endocrinology; 2015 Aug; 156(8):2880-92. PubMed ID: 25993525
[TBL] [Abstract][Full Text] [Related]
15. Autocrine prolactin inhibits human uterine decidualization: a novel role for prolactin.
Eyal O; Jomain JB; Kessler C; Goffin V; Handwerger S
Biol Reprod; 2007 May; 76(5):777-83. PubMed ID: 17267700
[TBL] [Abstract][Full Text] [Related]
16. [Progress in prolactin receptor research].
Tan DY; Peng XP
Sheng Li Ke Xue Jin Zhan; 2012 Feb; 43(1):17-23. PubMed ID: 22582593
[TBL] [Abstract][Full Text] [Related]
17. Discovery of the improved antagonistic prolactin variants by library screening.
Liu Y; Gong W; Breinholt J; Nørskov-Lauritsen L; Zhang J; Ma Q; Chen J; Panina S; Guo W; Li T; Zhang J; Kong M; Liu Z; Mao J; Christensen L; Hu S; Wang L
Protein Eng Des Sel; 2011 Nov; 24(11):855-60. PubMed ID: 21954059
[TBL] [Abstract][Full Text] [Related]
18. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.
Lim JH; Kim TY; Kim WH; Park JW
Breast Cancer Res Treat; 2011 Nov; 130(1):19-27. PubMed ID: 21128111
[TBL] [Abstract][Full Text] [Related]
19. Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice.
Ling C; Hellgren G; Gebre-Medhin M; Dillner K; Wennbo H; Carlsson B; Billig H
Endocrinology; 2000 Oct; 141(10):3564-72. PubMed ID: 11014209
[TBL] [Abstract][Full Text] [Related]
20. Internal image anti-idiotypic antibody: A new strategy for the development a new category of prolactin receptor (PRLR) antagonist.
Lan H; Hong P; Li R; L S; Anshan S; Li S; Zheng X
Mol Immunol; 2017 Jul; 87():86-93. PubMed ID: 28412548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
